Tom Frew

Agreement “Strengthens Intellectual Property Estate Around TRC102 and Provides Opportunity for Development of Additional Predictive Biomarkers” TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases, announced...

For $134 million Epiq Systems (Nasdaq:EPIQ), a global provider of integrated technology solutions for the legal profession, announced today that the company has signed a definitive agreement to acquire privately-held, Kansas City-based Iris Data Services, the market leading provider of managed services for electronic discovery (eDiscovery). The total consideration for the acquisition is $134...

Quarterly Operations Update for the Period Ended 31 March 2015 Magnolia Petroleum Plc, the AIM quoted US focused oil and gas exploration and production company, has announced a quarterly update on its operations across proven and producing US onshore hydrocarbon formations, including the Bakken/Three Forks Sanish in North Dakota and Montana, and the Woodford, Mississippi […]

Who is the new at the top? Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that P. David Mozley, M.D. has been appointed as vice president of imaging. Dr. Mozley will provide […]

Key information below Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that a 20-to-1 reverse split of its common stock will be effective at 5:00 p.m. EDT on April 8, 2015, and commencing at the open of trading on Thursday, April 9, 2015, trading of the common stock will continue […]

What next for Willis? Willis Group Holdings plc (NYSE:WSH), the global risk adviser, insurance and reinsurance broker, announced today it has acquired Carsa Consultores, a leading broker in Mexico. The move strengthens and supports Willis Mexico’s existing business, while also expanding its overall footprint, especially in the northwest region of Mexico, creating a new combined […]

How will they use the funds? Cellular Biomedicine Group Inc. (Nasdaq:CBMG), a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced the closing of a private placement transaction under which it sold an aggregate of 515,789 shares of the Company’s common stock, par value $0.001 per share, to […]

Initiation of Fuji’s Phase 2 Trial for 1404 Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that its partner, FUJIFILM RI Pharma, has dosed the first patient in its early Phase 2 trial of 1404 in Japan in newly-diagnosed prostate cancer patients with lymph node and/or bone metastases or at high risk for metastatic disease. 1404 is […]

Signs Hydro-Electric Collaboration Agreement in Liberia Hummingbird Resources, the multi-project gold company, is pleased to announce it has signed a collaboration agreement to embark on the planning and development of a 20-30MW hydro-electric power plant in southeast Liberia, Africa, in an area ±10km km from Hummingbird’s 4.2Moz Dugbe 1 Gold Project. The Agreement has been […]

Application for Mining Licence at Tongo Kimberlite Project, Sierra Leone Stellar Diamonds, a London listed (LSE:STEL) diamond development company focused on West Africa, announces that it has commenced the application process for a mining licence at its 100% owned 1.45 million carat Tongo Dyke-1 kimberlite project in eastern Sierra Leone. This is as a result […]